Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes

Both vitamin D deficiency and inflammation have been linked to cardiovascular disease, the major cause of death in diabetes. In this study, the effects of daily intake of vitamin D‐fortified yoghourt drink (doogh) on systemic inflammatory biomarkers in subjects with type 2 diabetes (T2D) were investigated.

[1]  C. Mathieu,et al.  Vitamin D and diabetes: Its importance for beta cell and immune function , 2011, Molecular and Cellular Endocrinology.

[2]  S. Shab-Bidar,et al.  Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial , 2011, BMC medicine.

[3]  S. Shab-Bidar,et al.  Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial , 2011, BMC endocrine disorders.

[4]  S. Salekzamani,et al.  Is vitamin D status a determining factor for metabolic syndrome? A case-control study , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.

[5]  P. Grant,et al.  Inflammation and thrombosis in diabetes , 2011, Thrombosis and Haemostasis.

[6]  M. Kiely,et al.  Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. , 2011, The Journal of nutrition.

[7]  M. Eshraghian,et al.  High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert , 2011, Public Health Nutrition.

[8]  D. Feldman,et al.  Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. , 2011, Annual review of pharmacology and toxicology.

[9]  G. Pierce,et al.  25-Hydroxyvitamin D Deficiency Is Associated With Inflammation-Linked Vascular Endothelial Dysfunction in Middle-Aged and Older Adults , 2011, Hypertension.

[10]  S. Shab-Bidar,et al.  Efficacy of vitamin D 3-fortified-yogurt drink on anthropometric , metabolic , inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients : a study protocol for a randomized controlled clinical trial , 2011 .

[11]  F. Bazzoni,et al.  Understanding the molecular mechanisms of the multifaceted IL‐10‐mediated anti‐inflammatory response: Lessons from neutrophils , 2010, European journal of immunology.

[12]  J. Aloia,et al.  Vitamin D and Serum Cytokines in a Randomized Clinical Trial , 2010, International journal of endocrinology.

[13]  J. Vendrell,et al.  Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? , 2010, Endocrine.

[14]  E. Hyppönen,et al.  25-Hydroxyvitamin D and Pre-Clinical Alterations in Inflammatory and Hemostatic Markers: A Cross Sectional Analysis in the 1958 British Birth Cohort , 2010, PloS one.

[15]  J. McNeil,et al.  Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? , 2010, The American journal of medicine.

[16]  N. Marchionni,et al.  Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[17]  R. Flavell,et al.  Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. , 2009, Current opinion in pharmacology.

[18]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[19]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[20]  E. Dupont,et al.  UV-induced immunosuppressive and anti-inflammatory actions: mechanisms and clinical applications. , 2009, Immunotherapy.

[21]  P. Witting,et al.  Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. , 2009, Atherosclerosis.

[22]  T. Neyestani,et al.  Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions , 2009, International journal of food sciences and nutrition.

[23]  Jeong-Ho Kim,et al.  Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. , 2008, Annals of clinical and laboratory science.

[24]  T. Neyestani,et al.  IRANIAN DIABETICS MAY NOT BE VITAMIN D DEFICIENT MORE THAN HEALTHY SUBJECTS , 2008 .

[25]  A. Bitto,et al.  Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. , 2008, European journal of pharmacology.

[26]  Nicholas J Wareham,et al.  Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer--Norfolk prospective study. , 2008, Archives of internal medicine.

[27]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[28]  G. Lippi,et al.  Relationship between serum vitamin D and inflammatory markers in the general population: comment on the article by Patel et al. , 2008, Arthritis and rheumatism.

[29]  Silvia Maggini,et al.  Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses , 2007, British Journal of Nutrition.

[30]  T. Neyestani,et al.  Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. , 2007, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[31]  A. Silman,et al.  Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. , 2007, Arthritis and rheumatism.

[32]  C. Mathieu,et al.  Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.

[33]  D. Jacobs,et al.  Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. , 2007, Clinical chemistry.

[34]  P. Monteagudo,et al.  Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes. , 2007, Immunology letters.

[35]  G. Targher,et al.  Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients , 2006, Clinical endocrinology.

[36]  Xujing Wang,et al.  Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. , 2006, American journal of epidemiology.

[37]  K. Hagihara,et al.  Analysis of cytokine-driven serum amyloid A expression based on the clinical results of IL-6 blocking therapy : a new cis-acting mechanism of STAT3 , 2006 .

[38]  J. Manson,et al.  Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women. , 2006, American journal of epidemiology.

[39]  Kyra Whitmer,et al.  C-reactive protein and cardiovascular disease in people with diabetes: high-sensitivity CRP testing can help assess risk for future cardiovascular disease events in this population. , 2006, The American journal of nursing.

[40]  Da-Wei Gong,et al.  Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications , 2006, PLoS medicine.

[41]  S. Cummings,et al.  Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene , 2006, Menopause.

[42]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[43]  M. Holick.  The vitamin D epidemic and its health consequences. , 2005, The Journal of nutrition.

[44]  M. Mccarty,et al.  Secondary hyperparathyroidism promotes the acute phase response -- a rationale for supplemental vitamin D in prevention of vascular events in the elderly. , 2005, Medical hypotheses.

[45]  Nader Rifai,et al.  Inflammatory markers and risk of developing type 2 diabetes in women. , 2004, Diabetes.

[46]  K. Hagihara,et al.  IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. , 2004, Biochemical and biophysical research communications.

[47]  G. Siest,et al.  IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. , 2003, Atherosclerosis.

[48]  J. Pickup,et al.  Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[49]  D. Mannino,et al.  C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults , 2003, European Journal of Clinical Nutrition.

[50]  M. Gannagé-Yared,et al.  Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women , 2003, Journal of endocrinological investigation.

[51]  G. Van den Berghe,et al.  Bone turnover in prolonged critical illness: effect of vitamin D , 2003, The Journal of clinical endocrinology and metabolism.

[52]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[53]  F. Pattou,et al.  1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. , 2002, Endocrinology.

[54]  G. Hitman,et al.  Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? , 2002, QJM : monthly journal of the Association of Physicians.

[55]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[56]  V. Janout,et al.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. , 2002, The Journal of clinical endocrinology and metabolism.

[57]  P. Macfarlane,et al.  The prognostic value of the electrocardiogram in the west of Scotland coronary prevention study , 2002 .

[58]  N. Herity.  Interleukin 6: a message from the heart , 2000, Heart.

[59]  A. Campa,et al.  A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. , 2000, Biochemical and biophysical research communications.

[60]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[61]  D. Rogers,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .

[62]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[63]  N. Golden,et al.  in Women with , 1992 .

[64]  J. Gauldie,et al.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. , 1990, Molecular biology & medicine.

[65]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.